Reported about 1 year ago
The impact of COVID-19 and the Russia-Ukraine conflict have accelerated the global drug shortage issue, with the FDA revealing the latest tracking situation. 'Alinamin Tablet 60mg,' which holds a 31% market share and is used to relieve cold or allergy symptoms, is currently in short supply due to raw material problems and is expected to return to normal supply by mid-June. The FDA has integrated and expanded five categories of drug platforms, including Western medicine, Chinese medicine, children's difficult access, rare diseases, and vaccines, to address the shortage challenge.
Source: YAHOO